Medindia

X

Alexza Reports 2011 First Quarter Financial Results and Provides Business Update

Wednesday, May 11, 2011 General News J E 4
Advertisement
AZ-004 (Staccato® Loxapine) NDA Target Resubmission Date of July 2011

ALEXZA PHARMACEUTICALS, INC.

(a development stage company)

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

March 31,

December 31,

2011

2010(1)

Assets

   Cash, cash equivalents and marketable securities

$          31,840

$         41,449

   Other current assets                              

670

965

      Total current assets  

32,510

42,414

   Property and equipment, net

23,248

24,361

   Other non-current assets

465

1,707

      Total assets

$         56,223

$        68,482

Liabilities and stockholders' equity (deficit)

   Current liabilities

$          30,644

$         34,383

   Non-current liabilities

21,239

21,809

   Stockholders' equity (deficit)

4,340

12,290

      Total liabilities and stockholders' equity (deficit)

$          56,223

$        68,482

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
GenVec Reports First Quarter 2011 Financial Result...
S
Medifast, Inc. Announces Record First Quarter 2011...